How do health disparities contribute to higher prevalence and worsening outcomes in type 2 diabetes, and how can we make more equitable care a reality?
A new national survey shines a light on what older adults with type 2 diabetes want from their Medicare Advantage plan.
Guidance on diabetes solutions for employers in a fragmented ecosystem from EHIR, the Employee Health Innovation Roundtable.
The Validation Institute has now awarded Virta three distinct validations for savings, outcomes and comprehensive program.
Is it possible to reverse diabetes? New research says yes. Go behind the scenes of the revolution happening in diabetes care.
A new strategy toolkit to help benefits leaders evaluate solutions to address metabolic health, including sample RFP questions.
ROI claims are as plentiful as the number of point solutions in digital health, so Virta’s research team recently undertook a study to understand the financial impacts of our diabetes reversal treatment using a claims-based analysis.
Validation Institute's analysis finds that Virta's diabetes reversal treatment drives estimated medication cost savings of nearly $6k per patient over 2 years.
We use cookies on our site to give you the best experience possible. By continuing to browse the site, you agree to this use. For more information on how we use cookies, see our Privacy Policy.
